Compare Stocks: RYM, ACB, DERM, and LFCR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACB Aurora Cannabis	$3.79 -0.8%	$2.90	$2.56 ▼ $6.66	$247.70M	0.58	1.73 million shs	2.85 million shs
DERM Journey Medical	$6.65 +3.4%	$6.59	$4.31 ▼ $9.56	$177.05M	1.08	178,550 shs	705,242 shs
LFCR Lifecore Biomedical	$4.73 -0.8%	$4.97	$3.63 ▼ $8.98	$180.56M	1.08	144,982 shs	93,490 shs
RYM RYTHM	$21.22 +3.1%	$23.73	$14.00 ▼ $53.65	$44.87M	9.47	13,672 shs	2,029 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACB Aurora Cannabis	-0.79%	+27.18%	+42.48%	+14.16%	-31.46%
DERM Journey Medical	+3.42%	+1.84%	-6.60%	+5.06%	-8.28%
LFCR Lifecore Biomedical	-0.84%	-2.27%	+2.60%	+7.50%	-38.89%
RYM RYTHM	+3.08%	-3.88%	-6.17%	-24.23%	+2,122,399,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACB Aurora Cannabis	$3.79 -0.8%	$2.90	$2.56 ▼ $6.66	$247.70M	0.58	1.73 million shs	2.85 million shs
DERM Journey Medical	$6.65 +3.4%	$6.59	$4.31 ▼ $9.56	$177.05M	1.08	178,550 shs	705,242 shs
LFCR Lifecore Biomedical	$4.73 -0.8%	$4.97	$3.63 ▼ $8.98	$180.56M	1.08	144,982 shs	93,490 shs
RYM RYTHM	$21.22 +3.1%	$23.73	$14.00 ▼ $53.65	$44.87M	9.47	13,672 shs	2,029 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACB Aurora Cannabis	-0.79%	+27.18%	+42.48%	+14.16%	-31.46%
DERM Journey Medical	+3.42%	+1.84%	-6.60%	+5.06%	-8.28%
LFCR Lifecore Biomedical	-0.84%	-2.27%	+2.60%	+7.50%	-38.89%
RYM RYTHM	+3.08%	-3.88%	-6.17%	-24.23%	+2,122,399,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACB Aurora Cannabis	2.50	Moderate Buy	N/A	N/A
DERM Journey Medical	2.25	Hold	$14.00	110.53% Upside
LFCR Lifecore Biomedical	2.00	Hold	$6.50	37.42% Upside
RYM RYTHM	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest RYM, ACB, DERM, and LFCR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2026	DERM Journey Medical	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$12.00 ➝ $15.00
8/11/2026	ACB Aurora Cannabis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (E+)
8/7/2026	ACB Aurora Cannabis	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/5/2026	ACB Aurora Cannabis	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
8/4/2026	LFCR Lifecore Biomedical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/29/2026	LFCR Lifecore Biomedical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/17/2026	DERM Journey Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/30/2026	LFCR Lifecore Biomedical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
6/16/2026	ACB Aurora Cannabis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D)
6/16/2026	LFCR Lifecore Biomedical	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$6.00 ➝ $6.50
5/18/2026	RYM RYTHM	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACB Aurora Cannabis	$247.82M	0.99	$0.70 per share	5.44	$5.87 per share	0.65
DERM Journey Medical	$61.86M	2.96	N/A	N/A	$0.96 per share	6.93
LFCR Lifecore Biomedical	$128.87M	1.39	N/A	N/A	($0.90) per share	-5.26
RYM RYTHM	$17.28M	2.68	N/A	N/A	$17.94 per share	1.18

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACB Aurora Cannabis	-$88.13M	-$1.41	N/A	63.17	N/A	-32.26%	4.37%	3.45%	N/A
DERM Journey Medical	-$11.43M	-$0.37	N/A	4.59	N/A	-8.95%	-20.67%	-6.75%	N/A
LFCR Lifecore Biomedical	N/A	-$1.07	N/A	N/A	N/A	-29.93%	N/A	-16.16%	10/2/2026 (Estimated)
RYM RYTHM	-$33.26M	-$10.53	N/A	N/A	N/A	-6.20%	-12.57%	-2.60%	N/A

Latest RYM, ACB, DERM, and LFCR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	DERM Journey Medical	-$0.0225	-$0.01	+$0.0125	-$0.01	$18.36 million	$18.51 million
8/5/2026	Q1 2027	ACB Aurora Cannabis	-$0.13	$0.04	+$0.17	-$0.05	$47.45 million	$47.62 million
8/5/2026	Q2 2026	LFCR Lifecore Biomedical	-$0.19	-$0.19	N/A	-$0.19	$34.18 million	$34.17 million
8/4/2026	Q2 2026	RYM RYTHM	N/A	$0.09	N/A	$0.09	N/A	$23.02 million
6/11/2026	Q4 2026	ACB Aurora Cannabis	-$0.07	$0.07	+$0.14	$0.86	$54.42 million	$60.98 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACB Aurora Cannabis	N/A	N/A	N/A	N/A	N/A
DERM Journey Medical	N/A	N/A	N/A	N/A	N/A
LFCR Lifecore Biomedical	N/A	N/A	N/A	N/A	N/A
RYM RYTHM	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACB Aurora Cannabis	0.03	5.36	2.80
DERM Journey Medical	0.74	1.72	1.47
LFCR Lifecore Biomedical	N/A	3.87	2.69
RYM RYTHM	N/A	0.59	0.56

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACB Aurora Cannabis	47.63%
DERM Journey Medical	7.25%
LFCR Lifecore Biomedical	83.36%
RYM RYTHM	5.98%

Insider Ownership

Company	Insider Ownership
ACB Aurora Cannabis	0.01%
DERM Journey Medical	14.53%
LFCR Lifecore Biomedical	32.68%
RYM RYTHM	3.48%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACB Aurora Cannabis	1,028	64.84 million	61.94 million	Optionable
DERM Journey Medical	90	27.53 million	23.53 million	N/A
LFCR Lifecore Biomedical	690	37.85 million	25.48 million	Optionable
RYM RYTHM	140	2.18 million	2.10 million	N/A

RYM, ACB, DERM, and LFCR Headlines

Recent News About These Companies

RYTHM Shareholders Approve Dilutive Equity Issuance Changes

August 11 at 7:51 AM | tipranks.com

RYTHM Swings to Earnings in Q2 on THC Beverage Growth

August 7, 2026 | zacks.com

RYTHM, Inc. Reports Record Second-Quarter 2026 Revenue Growth and Strong THC Beverage Momentum

August 4, 2026 | quiverquant.comQ

RYTHM, Inc. Reports Second Quarter 2026 Results

August 4, 2026 | globenewswire.com

RYTHM (NASDAQ:RYM) Trading Up 14% – Time to Buy?

August 4, 2026 | defenseworld.netD

RYTHM (NASDAQ:RYM) Shares Up 14% - Time to Buy?

August 4, 2026 | americanbankingnews.com

RYTHM, Inc. (RYM) Stock Major Holders - Yahoo Finance

July 27, 2026 | ca.finance.yahoo.com

Señorita Brings THC Beverages to Lollapalooza for the First Time

July 23, 2026 | globenewswire.com

Rythm Stock Short Interest Report | NASDAQ:RYM | Benzinga

July 17, 2026 | benzinga.com

RYTHM (NASDAQ:RYM) Director Sells 2,250 Shares

June 19, 2026 | insidertrades.com

RYTHM Inc.

May 16, 2026 | marketwatch.com

Señorita Named Official THC Beverage Partner of Opry Entertainment Group Venues

May 14, 2026 | globenewswire.com

Rythm Inc Ordinary Shares RYM

May 13, 2026 | morningstar.comM

RYTHM Stock Price History

May 12, 2026 | investing.com

RYTHM's Q1 Earnings Rise Y/Y on Licensing Agreement Benefits

May 11, 2026 | zacks.com

Navy Pier Names RYTHM as Its Official THC Beverage Partner

May 8, 2026 | globenewswire.com

RYTHM, Inc. Reports First Quarter 2026 Results

May 5, 2026 | globenewswire.com

Turning nursery rhymes into lifelong learning moments

April 26, 2026 | msn.com

RYTHM Sets Fixed Licensing Fees to Support Listing

April 4, 2026 | theglobeandmail.com

RYM stock surges 45%, breaches 100-DMA for first time in over three months – what triggered this rally?

April 1, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

RYM, ACB, DERM, and LFCR Company Descriptions

Aurora Cannabis NASDAQ:ACB

$3.79 -0.03 (-0.79%)

Closing price 08/13/2026 04:00 PM Eastern

Extended Trading

$3.76 -0.03 (-0.79%)

As of 08:27 AM Eastern

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Journey Medical NASDAQ:DERM

$6.65 +0.22 (+3.42%)

Closing price 08/13/2026 04:00 PM Eastern

Extended Trading

$6.66 +0.01 (+0.23%)

As of 07:21 AM Eastern

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. In addition, the company sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.

Lifecore Biomedical NASDAQ:LFCR

$4.73 -0.04 (-0.84%)

Closing price 08/13/2026 04:00 PM Eastern

Extended Trading

$4.59 -0.14 (-2.92%)

As of 08:30 AM Eastern

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

RYTHM NASDAQ:RYM

$21.22 +0.63 (+3.08%)

Closing price 08/13/2026 03:58 PM Eastern

Extended Trading

$23.51 +2.29 (+10.77%)

As of 08:30 AM Eastern

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RYM, ACB, DERM, and LFCR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RYM, ACB, DERM, and LFCR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RYM, ACB, DERM, and LFCR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

RYM, ACB, DERM, and LFCR Company Descriptions

Aurora Cannabis NASDAQ:ACB

Journey Medical NASDAQ:DERM

Lifecore Biomedical NASDAQ:LFCR

RYTHM NASDAQ:RYM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RYM, ACB, DERM, and LFCR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RYM, ACB, DERM, and LFCR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RYM, ACB, DERM, and LFCR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

RYM, ACB, DERM, and LFCR Company Descriptions

Aurora Cannabis NASDAQ:ACB

Journey Medical NASDAQ:DERM

Lifecore Biomedical NASDAQ:LFCR

RYTHM NASDAQ:RYM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools